| Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study A Sáez-Cirión, C Bacchus, L Hocqueloux PLoS Pathog. 9 (3), e1003211, 2013 | 1150 | 2013 |
| Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. NJD NSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S ... N Engl J Med. 373 (9), 795-807, 2015 | 1137 | 2015 |
| Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial F Carrat, F Bani-Sadr, S Pol, E Rosenthal, F Lunel-Fabiani, A Benzekri, ... Jama 292 (23), 2839-2848, 2004 | 1018 | 2004 |
| Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications P Nahon, V Bourcier, R Layese, E Audureau, C Cagnot, P Marcellin, ... Gastroenterology 152 (1), 142-156. e2, 2017 | 576 | 2017 |
| Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals JH Darbyshire Lancet 353 (9168), 1923-1929, 1996 | 561 | 1996 |
| The Effect of Combined Antiretroviral Therapy on the Overall Mortality of HIV-infected Individuals et al. HIV-CAUSAL Collaboration, Ray M, Logan R AIDS 24 (1), 123-37, 2010 | 549 | 2010 |
| Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of … C Lewden, D Salmon, P Morlat, S Bévilacqua, E Jougla, B Fabrice, ... International Journal of Epidemiology, 121-130, 2005 | 494 | 2005 |
| Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study F Dromer, S Mathoulin-Pélissier, O Launay PLoS Med. 4 (2), e21, 2007 | 458 | 2007 |
| Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The "Mortalité 2000 and 2005" Surveys (ANRS EN19 and Mortavic) C Lewden, T May, E Rosenthal J Acquir Immune Defic Syndr 48 (5), 590-595, 2008 | 448 | 2008 |
| Interleukin-2 therapy in patients with HIV infection. I therapy in patients with HIV infection. INSIGHT-ESPRIT Study Group, ... N Engl J Med. 361, 1548-59, 2009 | 427* | 2009 |
| Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers O Lambotte, G Ferrari, C Moog AIDS 23 (8), 897–906, 2009 | 408 | 2009 |
| Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study) E Rosenthal, M Poirée, C Pradier, C Perronne, D Salmon-Ceron, ... AIDS 17, 1803–1809, 2003 | 357 | 2003 |
| When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-defining Illness in HIV-infected Persons in Developed Countries: An Observational Study et al HIV-CAUSAL Collaboration, Cain LE, Logan R Ann Intern Med 154 (8), 509-15, 2011 | 344 | 2011 |
| Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000 P Morlat, C Roussillon, S Henard, D Salmon, F Bonnet, P Cacoub, ... AIDS, 1181–1191, 2014 | 321 | 2014 |
| PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma A Beldi-Ferchiou, M Lambert, S Dogniaux, F Vély, E Vivier, D Olive, ... Oncotarget 7 (45), 72961, 2016 | 304 | 2016 |
| Increased risk of lipoatrophy under stavudine in HIV-1-infected patients results of a substudy from a comparative trial V Joly, P Flandre, V Meiffredy, N Leturque, M Harel, JP Aboulker, P Yeni AIDS 16 (18), 2447-2454, 2002 | 261 | 2002 |
| CD4 Cell Count and HIV DNA Level Are Independent Predictors of Disease Progression after Primary HIV Type 1 Infection in Untreated Patients C Goujard, M Bonarek, L Meyer, F Bonnet, ML Chaix, C Deveau, M Sinet, ... Clinical Infectious Diseases 42, 709–15, 2006 | 256 | 2006 |
| Neurosteroids: biosynthesis, metabolism and function of pregnenolone and dehydroepiandrosterone in the brain. HZY Akwa Y, Young J, Kabbadj K, Sancho MJ, Zucman D, Vourc'h C, Jung-Testas I J Steroid Biochem Mol Biol. 40, 71-81., 1991 | 230 | 1991 |
| Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs P Nahon, R Layese, V Bourcier, C Cagnot, P Marcellin, D Guyader, S Pol, ... Gastroenterology 155 (5), 1436-1450. e6, 2018 | 229 | 2018 |
| Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 … F raffi lancet, 2014 | 229 | 2014 |
Dominique CostagliolaDirectrice de Recherche Emérite INSERMVerified email at inserm.fr
